Skip to main content
NCBI home page
Journal of Psychiatry & Neuroscience : JPN logoLink to Journal of Psychiatry & Neuroscience : JPN
letter
. 1993 Jul;18(4):199–200.

New mechanisms of action of irreversible monoamine oxidase type B inhibitors.

X M Li, A V Juorio, I A Paterson, A A Boulton
PMCID: PMC1188531  PMID: 8373757

Full text

PDF
199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkmayer W., Riederer P., Youdim M. B., Linauer W. The potentiation of the anti akinetic effect after L-dopa treatment by an inhibitor of MAO-B, Deprenil. J Neural Transm. 1975;36(3-4):303–326. doi: 10.1007/BF01253131. [DOI] [PubMed] [Google Scholar]
  2. Hadjiconstantinou M., Rossetti Z., Silvia C., Krajnc D., Neff N. H. Aromatic L-amino acid decarboxylase activity of the rat retina is modulated in vivo by environmental light. J Neurochem. 1988 Nov;51(5):1560–1564. doi: 10.1111/j.1471-4159.1988.tb01125.x. [DOI] [PubMed] [Google Scholar]
  3. Höper J., Kozniewska E. Attenuation of hypoxic response in cerebral microcirculation following deprenyl. Int J Microcirc Clin Exp. 1992 Aug;11(3):287–295. [PubMed] [Google Scholar]
  4. Li X. M., Juorio A. V., Paterson I. A., Walz W., Zhu M. Y., Boulton A. A. Gene expression of aromatic L-amino acid decarboxylase in cultured rat glial cells. J Neurochem. 1992 Sep;59(3):1172–1175. doi: 10.1111/j.1471-4159.1992.tb08363.x. [DOI] [PubMed] [Google Scholar]
  5. Li X. M., Juorio A. V., Paterson I. A., Zhu M. Y., Boulton A. A. Specific irreversible monoamine oxidase B inhibitors stimulate gene expression of aromatic L-amino acid decarboxylase in PC12 cells. J Neurochem. 1992 Dec;59(6):2324–2327. doi: 10.1111/j.1471-4159.1992.tb10127.x. [DOI] [PubMed] [Google Scholar]
  6. Marsden C. D. Parkinson's disease. Lancet. 1990 Apr 21;335(8695):948–952. doi: 10.1016/0140-6736(90)91006-v. [DOI] [PubMed] [Google Scholar]
  7. Matsui Y., Kumagae Y. Monoamine oxidase inhibitors prevent striatal neuronal necrosis induced by transient forebrain ischemia. Neurosci Lett. 1991 May 27;126(2):175–178. doi: 10.1016/0304-3940(91)90547-7. [DOI] [PubMed] [Google Scholar]
  8. Paterson I. A., Juorio A. V., Boulton A. A. Possible mechanism of action of deprenyl in parkinsonism. Lancet. 1990 Jul 21;336(8708):183–183. doi: 10.1016/0140-6736(90)91709-j. [DOI] [PubMed] [Google Scholar]
  9. Salo P. T., Tatton W. G. Deprenyl reduces the death of motoneurons caused by axotomy. J Neurosci Res. 1992 Feb;31(2):394–400. doi: 10.1002/jnr.490310223. [DOI] [PubMed] [Google Scholar]
  10. Tatton W. G., Greenwood C. E. Rescue of dying neurons: a new action for deprenyl in MPTP parkinsonism. J Neurosci Res. 1991 Dec;30(4):666–672. doi: 10.1002/jnr.490300410. [DOI] [PubMed] [Google Scholar]
  11. Zhu M. Y., Juorio A. V., Paterson I. A., Boulton A. A. Regulation of aromatic L-amino acid decarboxylase by dopamine receptors in the rat brain. J Neurochem. 1992 Feb;58(2):636–641. doi: 10.1111/j.1471-4159.1992.tb09765.x. [DOI] [PubMed] [Google Scholar]
  12. Zsilla G., Földi P., Held G., Székely A. M., Knoll J. The effect of repeated doses of (-) deprenyl on the dynamics of monoaminergic transmission. Comparison with clorgyline. Pol J Pharmacol Pharm. 1986 Jan-Feb;38(1):57–67. [PubMed] [Google Scholar]

Articles from Journal of Psychiatry and Neuroscience are provided here courtesy of Canadian Science Publishing

RESOURCES